List of Esomeprazole Magnesium drug patents

Esomeprazole Magnesium is owned by Dexcel Pharma.

Esomeprazole Magnesium contains Esomeprazole Magnesium.

Esomeprazole Magnesium has a total of 2 drug patents out of which 0 drug patents have expired.

Esomeprazole Magnesium was authorised for market use on 20 October, 2020.

Esomeprazole Magnesium is available in tablet, orally disintegrating, delayed release;oral dosage forms.

The generics of Esomeprazole Magnesium are possible to be released after 08 December, 2036.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10076494 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

US10835488 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

Drugs and Companies using ESOMEPRAZOLE MAGNESIUM ingredient

Market Authorisation Date: 20 October, 2020

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic